Nutraceutical Corporation is pleased to announce that Dr. Raphael Kellman, MD will be advising the company in the development and promotion of its Solaray® Mycrobiome® Probiotic line of products. Dr. Kellman is a best-selling author […]
Microbiome-focused companies have many different areas of interest—but what they have in common is a drive to learn more about the conditions and activities of bacteria and other microorganisms. Martha Carlin, CEO and co-founder of […]
Carbiotix, an award winning biotechnology start-up focused on optimizing gut health with soluble fiber (prebiotics), has closed a second pre-seed financing round of 450,000 Euros, bringing the total capital raised to date to 700,000 Euros. Participating in […]
Clalit Health Services, the leading HMO in Israel, and DayTwo are partnering to bring to market a glycemic-control product for people with Type 2 diabetes. The glycemic-control offering is based on the genetic sequencing of […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, announces the publication of a paper demonstrating that MRx0004, a live biotherapeutic derived from the human gut microbiome, can protect against […]
Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions of the microbiome organ, today announced that Alison Lawton, Kaleido’s president and chief operating officer (COO), has been appointed to […]
Nutrition Business Journal (NBJ) recently recognized the industry leadership of The BioCollective co-founder and CEO Martha Carlin by awarding her their annual prize for Science & Innovation. A recent NBJ feature article on Carlin […]
Over the last several years, there’s been growing scientific and public interest in the role of microorganisms in the maintenance of overall health and prevention and treatment of disease. Today, more so than ever before, […]
New research suggests that shifts in the bacteria within a child’s mouth could provide objective biomarkers for identifying autism spectrum disorder. The findings of this research, conducted by scientists from Penn State Medical Center, SUNY […]
The Microbiome Therapeutics Innovation Group (MTIG) announced the formation of their coalition which seeks to nurture innovation in microbiome therapeutics and microbiome-based products to address unmet medical needs and bring life-saving treatments to patients. The […]
Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, announced the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, […]